Ionis Pharmaceuticals

(NASDAQ) IONS

Current Price$74.57

Market Cap$12.36B

Since IPO (1991)+648%

5 Year+75%

1 Year+151%

1 Month+3%

Ionis Pharmaceuticals Financials at a Glance

Market Cap

$12.36B

Revenue (TTM)

$1.06B

Net Income (TTM)

$326.58M

EPS (TTM)

$-2.47

P/E Ratio

-30.34

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$74.57

Volume

77,911

Open

$74.93

Price

$74.57

Volume

77,911

Open

$74.93

Previous Close

$74.83

Daily Range

$73.81 - $77.58

52-Week Range

$30.01 - $86.74

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$74.57

Volume

77,911

Open

$74.93

Previous Close

$74.83

Daily Range

$73.81 - $77.58

52-Week Range

$30.01 - $86.74

IONS News

Doctor holding clipboard stands with virtual DNA double helix in the air near him.

Best Genomics Stocks for 2026 and How to Invest

Lyle DalyApr 18, 2026

Biotech scientist working on a tablet with bio-related icons projected above it.

Page 1

IONS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ionis Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

1,402

CEO

Brett P. Monia, PhD

Website

www.ionis.com

Headquarters

Carlsbad, CA 92010, US

IONS Financials

Key Financial Metrics (TTM)

Gross Margin

98%

Operating Margin

-33%

Net Income Margin

-31%

Return on Equity

-71%

Return on Capital

-13%

Return on Assets

-9%

Earnings Yield

-3.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.36B

Shares Outstanding

165.19M

Volume

77.91K

Avg. Volume

2.13M

Financials (TTM)

Gross Profit

$928.00M

Operating Income

$382.00M

EBITDA

$286.75M

Operating Cash Flow

$268.58M

Capital Expenditure

$51.44M

Free Cash Flow

$320.03M

Cash & ST Invst.

$2.68B

Total Debt

$2.61B

Ionis Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$246.09M

+87.0%

Gross Profit

$243.11M

+86.8%

Gross Margin

98.79%

N/A

Market Cap

$12.36B

N/A

Market Cap/Employee

$11.56M

N/A

Employees

1,069

N/A

Net Income

$92.53M

+37.0%

EBITDA

$117.42M

+2.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$321.85M

-272.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$5.56M

-51.7%

Long Term Debt

$2.24B

+15.1%

Short Term Debt

$0.00

-100.0%

Return on Assets

-9.47%

N/A

Return on Invested Capital

-12.91%

N/A

Free Cash Flow

$814.58M

-398.7%

Operating Cash Flow

$792.82M

-425.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MDGLMadrigal Pharmaceuticals, Inc.

MDGLMadrigal Pharmaceuticals, Inc.$518.11-0.09%

GHGuardant Health, Inc.

GHGuardant Health, Inc.$86.98+4.29%

EXELExelixis, Inc.

EXELExelixis, Inc.$44.50-0.43%

BBIOBridgeBio Pharma, Inc.

BBIOBridgeBio Pharma, Inc.$71.04+0.14%

ASNDAscendis Pharma A/S

ASNDAscendis Pharma A/S$229.06+3.99%

BMRNBioMarin Pharmaceutical Inc.

BMRNBioMarin Pharmaceutical Inc.$53.89-0.59%

SMMTSummit Therapeutics Inc.

SMMTSummit Therapeutics Inc.$21.52+3.34%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.71+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.56+0.08%

SOFISoFi Technologies

SOFISoFi Technologies$15.96+0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.60+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.49+0.05%

OWLBlue Owl Capital

OWLBlue Owl Capital$9.80+0.10%

GOOGLAlphabet

GOOGLAlphabet$381.12+0.09%

Questions About IONS

What is the current price of Ionis Pharmaceuticals?

Ionis Pharmaceuticals is trading at $74.57 per share.

What is the 52-week range for Ionis Pharmaceuticals?

Over the past 52 weeks, Ionis Pharmaceuticals has traded between $30.01 and $86.74.

How much debt does Ionis Pharmaceuticals have?

As of the most recent reporting period, Ionis Pharmaceuticals reported total debt of $2.61B.

How much cash does Ionis Pharmaceuticals have on hand?

Ionis Pharmaceuticals reported $173.38M in cash and cash equivalents in its most recent financial results.

What is Ionis Pharmaceuticals’s dividend yield?

Ionis Pharmaceuticals does not currently have a dividend yield.

Ionis Pharmaceuticals

Ionis Pharmaceuticals Financials at a Glance

IONS News

Best Genomics Stocks for 2026 and How to Invest

How to Invest in SPDR S&P Biotech ETF (XBI)

Capricorn Buys New Stake in Ionis Pharmaceuticals (IONS) With 163,000 Shares

Ionis (IONS) Q2 Revenue Soars 101%

Ionis Pharma Beats Expectations for Q4

Ionis Pharmaceuticals Beats on Revenue

2 Growth Stocks That Are Unapologetically Crushing the Bear Market

Why Ionis Pharmaceuticals Stock Is Down 13% This Week

IONS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ionis Pharmaceuticals

IONS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ionis Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IONS

What is the current price of Ionis Pharmaceuticals?

What is the 52-week range for Ionis Pharmaceuticals?

How much debt does Ionis Pharmaceuticals have?

How much cash does Ionis Pharmaceuticals have on hand?

What is Ionis Pharmaceuticals’s dividend yield?

Premium Investing Services